Abstract
Common arterial grafts used in coronary artery bypass grafting include internal thoracic artery (ITA), radial artery (RA) and right gastroepiploic artery (RGA) grafts; of these, the ITA has the best clinical outcome. Here, by analyzing the single-cell transcriptome of different arterial grafts, we suggest optimization strategies for the RA and RGA based on the ITA as a reference. Compared with the ITA, the RA had more lipid-handling-related CD36+ endothelial cells. Vascular smooth muscle cells from the RGA were more susceptible to spasm, followed by those from the RA; comparison with the ITA suggested that potassium channel openers may counteract vasospasm. Fibroblasts from the RA and RGA highly expressed GDF10 and CREB5, respectively; both GDF10 and CREB5 are associated with extracellular matrix deposition. Cell–cell communication analysis revealed high levels of macrophage migration inhibitory factor signaling in the RA. Administration of macrophage migration inhibitory factor inhibitor to mice with partial carotid artery ligation blocked neointimal hyperplasia induced by disturbed flow. Modulation of identified targets may have protective effects on arterial grafts.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The scRNA-seq data generated from this study have been deposited with Figshare at https://doi.org/10.6084/m9.figshare.24922941 (ref. 53). CellRanger v.5.0.1 was used with default parameters to map all the data from the samples to the human reference genome (GRCh38) provided by 10X Genomics. The bulk RNA-seq data (the cultured human VSMCs) generated from this study have been deposited with Zenodo at https://doi.org/10.5281/zenodo.10797867 (ref. 54). Source data are provided with this paper.
References
Gaudino, M. et al. The choice of conduits in coronary artery bypass surgery. J. Am. Coll. Cardiol. 66, 1729–1737 (2015).
Yi, G., Shine, B., Rehman, S. M., Altman, D. G. & Taggart, D. P. Effect of bilateral internal mammary artery grafts on long-term survival: a meta-analysis approach. Circulation 130, 539–545 (2014).
Locker, C. et al. Multiple arterial grafts improve late survival of patients undergoing coronary artery bypass graft surgery: analysis of 8622 patients with multivessel disease. Circulation 126, 1023–1030 (2012).
Tatoulis, J. et al. Long-term patency of 1108 radial arterial-coronary angiograms over 10 years. Ann. Thorac. Surg. 88, 23–29 (2009).
Tranbaugh, R. F. et al. Radial artery conduits improve long-term survival after coronary artery bypass grafting. Ann. Thorac. Surg. 90, 1165–1172 (2010).
Gaudino, M. et al. Mechanisms, consequences, and prevention of coronary graft failure. Circulation 136, 1749–1764 (2017).
Suma, H. et al. Twenty years experience with the gastroepiploic artery graft for CABG. Circulation 116, I188–I191 (2007).
Suzuki, T. et al. Early and long-term patency of in situ skeletonized gastroepiploic artery after off-pump coronary artery bypass graft surgery. Ann. Thorac. Surg. 96, 90–95 (2013).
Ruengsakulrach, P. et al. Comparative histopathology of radial artery versus internal thoracic artery and risk factors for development of intimal hyperplasia and atherosclerosis. Circulation 100, II139–II144 (1999).
Nakajima, T., Tachibana, K., Takagi, N., Ito, T. & Kawaharada, N. Histomorphologic superiority of internal thoracic arteries over right gastroepiploic arteries for coronary bypass. J. Thorac. Cardiovasc. Surg. 151, 1704–1708 (2016).
Kraler, S. et al. Resilience of the internal mammary artery to atherogenesis: shifting from risk to resistance to address unmet needs. Arterioscler. Thromb. Vasc. Biol. 41, 2237–2251 (2021).
He, G. W., Yang, C. Q. & Starr, A. Overview of the nature of vasoconstriction in arterial grafts for coronary operations. Ann. Thorac. Surg. 59, 676–683 (1995).
Oemar, B. S. et al. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 97, 2494–2498 (1998).
Polański, K. et al. BBKNN: fast batch alignment of single cell transcriptomes. Bioinformatics 36, 964–965 (2020).
Traag, V. A., Waltman, L. & van Eck, N. J. From Louvain to Leiden: guaranteeing well-connected communities. Sci. Rep. 9, 5233 (2019).
Wolock, S. L., Lopez, R. & Klein, A. M. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 8, 281–291 (2019).
van den Brink, S. C. et al. Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations. Nat. Methods 14, 935–936 (2017).
Lopez, R., Regier, J., Cole, M. B., Jordan, M. I. & Yosef, N. Deep generative modeling for single-cell transcriptomics. Nat. Methods 15, 1053–1058 (2018).
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
Chamiot-Clerc, P., Copie, X., Renaud, J. F., Safar, M. & Girerd, X. Comparative reactivity and mechanical properties of human isolated internal mammary and radial arteries. Cardiovasc. Res. 37, 811–819 (1998).
Beerkens, F. J. et al. Contemporary coronary artery bypass graft surgery and subsequent percutaneous revascularization. Nat. Rev. Cardiol. 19, 195–208 (2022).
Yung, L. M., Sánchez-Duffhues, G., Ten Dijke, P. & Yu, P. B. Bone morphogenetic protein 6 and oxidized low-density lipoprotein synergistically recruit osteogenic differentiation in endothelial cells. Cardiovasc. Res. 108, 278–287 (2015).
Tjwa, M. et al. Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood 111, 4096–4105 (2008).
Melnik, T., Jordan, O., Corpataux, J.-M., Delie, F. & Saucy, F. Pharmacological prevention of intimal hyperplasia: a state-of-the-art review. Pharmacol. Ther. 235, 108157 (2022).
Lu, Q.-B. et al. Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade. Redox Biol. 14, 656–668 (2018).
Fan, Y. et al. Macrophage migration inhibitory factor triggers vascular smooth muscle cell dedifferentiation by a p68-serum response factor axis. Cardiovasc. Res. 113, 519–530 (2017).
Davis, M. J. et al. Integrins and mechanotransduction of the vascular myogenic response. Am. J. Physiol. Heart Circ. Physiol. 280, H1427–H1433 (2001).
Stenmark, K. R. et al. The adventitia: essential regulator of vascular wall structure and function. Annu. Rev. Physiol. 75, 23–47 (2013).
Henderson, W. R. Jr. et al. Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc. Natl Acad. Sci. USA 107, 14309–14314 (2010).
Beyer, C. et al. β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis. Ann. Rheum. Dis. 71, 761–767 (2012).
Brandt, K. J. et al. Single-cell analysis uncovers osteoblast factor growth differentiation factor 10 as mediator of vascular smooth muscle cell phenotypic modulation associated with plaque rupture in human carotid artery disease. Int. J. Mol. Sci. 23, 1796 (2022).
Takeshita, S. et al. Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation. J. Clin. Invest. 123, 3914–3924 (2013).
Palumbo-Zerr, K. et al. Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis. Nat. Med. 21, 150–158 (2015).
Chen, P. et al. Orphan nuclear receptor NR4A2 inhibits hepatic stellate cell proliferation through MAPK pathway in liver fibrosis. PeerJ 3, e1518 (2015).
Cui, Y. et al. Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation. J. Clin. Invest. 125, 4171–4185 (2015).
Adlam, D. & Channon, K. M. Radial artery graft string sign due to lumen obliteration by neointima: insight from optical coherence tomography. JACC Cardiovasc. Interv. 4, 586–587 (2011).
Jin, S. et al. Inference and analysis of cell–cell communication using CellChat. Nat. Commun. 12, 1088 (2021).
Huang, H. et al. The small molecule macrophage migration inhibitory factor antagonist MIF098, inhibits pulmonary hypertension associated with murine SLE. Int. Immunopharmacol. 76, 105874 (2019).
Nakamura, A. et al. Macrophage migration inhibitory factor drives pathology in a mouse model of spondyloarthritis and is associated with human disease. Sci. Transl. Med. 13, eabg1210 (2021).
Nicholls, S. J. et al. Effect of evolocumab on coronary plaque composition. J. Am. Coll. Cardiol. 72, 2012–2021 (2018).
Goodman, S. G. et al. Effects of alirocumab on cardiovascular events after coronary bypass surgery. J. Am. Coll. Cardiol. 74, 1177–1186 (2019).
Cochain, C. et al. Single-cell RNA-seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis. Circ. Res. 122, 1661–1674 (2018).
Abumrad, N. A. et al. Endothelial cell receptors in tissue lipid uptake and metabolism. Circ. Res. 128, 433–450 (2021).
Veres, G. et al. Is internal thoracic artery resistant to reperfusion injury? Evaluation of the storage of free internal thoracic artery grafts. J. Thorac. Cardiovasc. Surg. 156, 1460–1469 (2018).
Picard, F., Sayah, N., Spagnoli, V., Adjedj, J. & Varenne, O. Vasospastic angina: a literature review of current evidence. Arch. Cardiovasc. Dis. 112, 44–55 (2019).
Beyer, C. et al. Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis. Ann. Rheum. Dis. 72, 1255–1258 (2013).
Wallace, D. J., Figueras, F., Wegener, W. A. & Goldenberg, D. M. Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE). Ann. Rheum. Dis. 80, 954–955 (2021).
Rammos, C. et al. Modulation of circulating macrophage migration inhibitory factor in the elderly. Biomed Res. Int. 2014, 582586 (2014).
Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).
Dai, M., Pei, X. & Wang, X.-J. Accurate and fast cell marker gene identification with COSG. Brief. Bioinform. 23, bbab579 (2022).
Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284–287 (2012).
Zhao, C.-R. et al. Vitexin inhibits APEX1 to counteract the flow-induced endothelial inflammation. Proc. Natl Acad. Sci. USA 118, e2115158118 (2021).
Zhan, H., Min, D., Yuan, C., Xiu-Jie, W. & Jiangping, S. The single-cell RNA-seq data generated in the study Strategies for Arterial Grafts Optimization at Single Cell Level. Figshare https://doi.org/10.6084/m9.figshare.24922941 (2024).
Yuan, C. The VSMC RNA-seq datasets for “Strategies for Arterial Grafts Optimization at Single Cell Level”. Zenodo https://doi.org/10.5281/zenodo.10797867 (2024).
Acknowledgements
We thank the National Natural Science Fund for Distinguished Young Scholars of China (grant no. 82125004), the Chinese Academy of Medical Sciences (CAMS) for the CAMS Innovation Fund for Medical Sciences (grant no. 2021-I2M-1-064), the National High Level Hospital Clinical Research Funding (2022-GSP-QZ-03, 2023-GSP-RC-03), the National Natural Science Foundation of China (grant no. 31570932), the Chinese Academy of Sciences for Young Scientists in Basic Research Project (grant no. YSBR-073) and the Beijing Municipal Science & Technology Commission (grant no. Z231100007223010).
Author information
Authors and Affiliations
Contributions
J.S. and X.-J.W. conceived and directed the study. Z.H., X.C., X.H. and H.Z. collected the arterial tissues and isolated the single cells for subsequent scRNA-seq. Z.H. and Y.C. performed the animal work. Y.S., N.Z., Z.X. and Y.C. performed the cell culture and immunostaining experiments. Y.Z., H.C. and H.J. performed the qPCR experiments. Y.C., M.D. and Z.H. analyzed the scRNA-seq data and reviewed the statistical methods. Z.H., M.D. and Y.C. wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Cardiovascular Research thanks Domenico Bruno, Joanna Kalucka and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 HE staining for ITA, RA, and RGA.
a. HE staining for ITA. b. HE staining for RA. c. HE staining for RGA. ITA: internal thoracic artery, RA: radial artery, RGA: right gastroepiploic artery. 2 independent experiments obtained the similar results (a-c).
Extended Data Fig. 2 Quality control (QC) analysis.
a. The data quality metrics before and after QC. b. The summary table of cell numbers after QC. c. Doublet detected by scrublet analysis. d. The evaluation of the proportion of stress gene expression caused by cell dissociation. e. The UMAP visualization of batch effect correction effects by scVI. f. The UMAP visualization of batch effect correction effects by Harmony.
Extended Data Fig. 3 Evaluation of individual batch effect.
UMAP distribution of Individual sample
Extended Data Fig. 4 Quantification of VSMC and FB in three types of arterial grafts.
a. α-SMA and VIM stain of ITA, RA, and RGA. b. The proportion of FB and VSMC in tunica media among three arterial grafts. c. EVG stain in ITA, RA, and RGA. d. Comparison of elastic fibers area among ITA, RA, and RGA. EVG: Verhoeff’s Van Gieson. Data are presented as mean ± s.e.m.; P values were calculated using one-way ANOVA unpaired multiple comparisons; n = 7, n = 7, and n = 3 biologically independent samples for ITA, RA, and RGA, respectively (b, d).
Extended Data Fig. 5 The distribution of VWF and EC0’s top marker before QC.
a. VWF indicated the location of EC on UMAP before QC (dashed circle). b. Enriched gene activities of EC0’s top marker genes on UMAP before QC (Black arrow). QC: Quality control.
Extended Data Fig. 6 Function analysis of EC8.
a. The expression of SEMA3G in EC0-EC9. b. GO function of EC8.
Extended Data Fig. 7 Immunofluorescence staining verification for ECs.
a. Validate high expression of ENDRB in RGA. Immunofluorescence staining for CD31 (Red), CLDN11 (Green), EDNRB (Yellow), and DAPI (Blue) among three arterial grafts. b. Mean fluorescence intensity of EDNRB in ECs among three arterial grafts. c. Validate high expression of PTGS2 and NOS3 in ITA. Immunofluorescence staining for CD31 (Red), PTGS2 (Green), NOS3 (Yellow), and DAPI (Blue) among three arterial grafts. d. Mean fluorescence intensity of PTGS2 and NOS3 in ECs among three arterial grafts. Data are presented as mean ± s.e.m.; P values were calculated using one-way ANOVA unpaired multiple comparisons; n = 7, n = 7, and n = 3 biologically independent samples for ITA, RA, and RGA, respectively (b, d).
Extended Data Fig. 8 Inhibition of CREB5 could reduce fibrosis.
a. The expression of WNT10B and CREB5 in FB0-FB4. b. Work flow for CREB5 inhibition in vascular adventitial fibroblasts. c. qPCR for COL1A1 after 24 hours of CREB5 inhibition by ICG-001. n=4 per group. d. Immunostaining for COL1A1 after 24 hours of CREB5 inhibition by ICG-001. 3 independent experiments with n=8 per group. e. Quantification of COL1A1. n=8 per group. f-g. Scratch experiment after CREB5 inhibition. n=4 per group. Data are presented as mean ± s.e.m.; P values were calculated using one-way ANOVA unpaired multiple comparisons (c, e, g).
Extended Data Fig. 9 GDF10 induced fibrosis.
a. Work flow for GDF10 stimulation in vascular adventitial fibroblasts. b. qPCR for COL1A1 and E2F1 after 24 hours of GDF10 stimulation. n=4 per group. c. Immunostaining for COL1A1 after 24 hours of GDF10 stimulation. 3 independent experiments with n=8 per group. d. Quantification of COL1A1. n=8 per group. e-f. Scratch experiment after CREB5 inhibition. n=4 per group. g. The expression of GDF10 receptor in FB0-FB4. h. The expression of TGFB related genes in FB0-FB4. i. The effect of GDF10. Data are presented as mean ± s.e.m.; P values were calculated using one-way ANOVA unpaired multiple comparisons (b, d, f).
Extended Data Fig. 10 Multicolor immunofluorescence validation in CAs.
a. PTGS2 and SEMA3G in ECs of CAs. b. LDLR and CD36 in ECs of CAs. c. CACNA1C and KCNMA1 in VSMCs of CAs. d. GDF10 and CTHRC1 in FBs of CAs. 2 independent experiments obtained the similar results (a-d).
Supplementary information
Supplementary Tables 1–4
Supplementary Table 1. Patients’ clinical information.
Table 2. Gene set for the score analysis.
Table 3. Marker genes for the cell subtypes.
Table 4. Summary of major cell types in arterial grafts.
Source data
Source Data Fig. 2
Statistical source data for Fig. 2.
Source Data Fig. 3
Statistical source data for Fig. 3.
Source Data Fig. 4
Statistical source data for Fig. 4.
Source Data Fig. 5
Statistical source data for Fig. 5.
Source Data Fig. 7
Statistical source data for Fig. 7.
Source Data Fig. 8
Statistical source data for Fig. 8.
Source Data Extended Data Fig. 4
Statistical source data for Extended Data Fig. 4.
Source Data Extended Data Fig. 7
Statistical source data for Extended Data Fig. 7.
Source Data Extended Data Fig. 8
Statistical source data for Extended Data Fig. 8.
Source Data Extended Data Fig. 9
Statistical source data for Extended Data Fig. 9.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hu, Z., Dai, M., Chang, Y. et al. Strategies for arterial graft optimization at the single-cell level. Nat Cardiovasc Res (2024). https://doi.org/10.1038/s44161-024-00464-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s44161-024-00464-6